cemsidomide
cemsidomide: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| C4 Therapeutics, Inc. (CCCC) | Phase 2 |
FDA Decisions
FDA_MeetingCompany expects to align with the FDA by year-end 2025 on a recommended Phase 2 dose for cemsidomide based on Phase 1 MM data and to initiate registrational development in early 2026.(CCCC)
Frequently asked questions
Who is developing cemsidomide?
cemsidomide is being developed by C4 Therapeutics, Inc..
What is cemsidomide's latest FDA decision?
The most recent tracked FDA decision for cemsidomide is FDA_Meeting for Company expects to align with the FDA by year-end 2025 on a recommended Phase 2 dose for cemsidomide based on Phase 1 MM data and to initiate registrational development in early 2026..
Get deeper analysis on cemsidomide
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis